On February 7, 2023, Jeffrey L. Cleland, Ph.D. tendered his resignation from the Board of Directors (the Board) of Exicure, Inc. (the Company) as well as from the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board, effective as of the earlier of: (1) the closing date of the Private Placement, or (2) February 10, 2023. Effective February 10, 2023, Dr. Cleland resigned from the Board, the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3142 USD | -0.32% | -3.77% | -45.86% |
17/06 | Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/06 | Earnings Flash (XCUR) EXICURE Reports Q1 Revenue $500,000 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.86% | 27.27L | |
+16.49% | 12TCr | |
+21.73% | 12TCr | |
+22.18% | 2.7TCr | |
-21.81% | 2.04TCr | |
-16.89% | 1.64TCr | |
-18.81% | 1.59TCr | |
-44.74% | 1.56TCr | |
+62.72% | 1.49TCr | |
+3.09% | 1.36TCr |
- Stock Market
- Equities
- XCUR Stock
- News Exicure, Inc.
- Exicure, Inc. Announces Resignation of Jeffrey L. Cleland from the Board of Directors, Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee